Average Co-Inventor Count = 11.80
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (18 from 1,970 patents)
2. Biovitrum Ab (4 from 55 patents)
3. Alterome Therapeutics, Inc. (3 from 3 patents)
4. University of California (2 from 15,458 patents)
5. California Institute of Technology (2 from 4,547 patents)
6. 1200 Pharma LLC (2 from 2 patents)
7. Teijin Pharma Limited (1 from 124 patents)
24 patents:
1. 12486280 - CDK inhibitors and uses thereof
2. 12466842 - Substituted pyrido [4,3-d]pyrimidines as KRAS modulators
3. 12428416 - ERK inhibitors and uses thereof
4. 12209087 - AKT1 modulators
5. 11999730 - AKT1 modulators
6. 11407721 - CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer
7. 11332459 - Benzimidazole derivatives and their uses
8. 11096939 - KRAS G12C inhibitors and methods of using the same
9. 11045484 - KRAS G12C inhibitors and methods of using the same
10. 10988485 - KRAS G12C inhibitors and methods of using the same
11. 9593129 - Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
12. 9376425 - Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
13. 9296736 - Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
14. 8686011 - Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
15. 8541592 - Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1